GlaxoSmithKline

Oct 21, 09 NEW STORY 13:46 ET CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women   Oct 08, 09 15:55 ET GlaxoSmithKline and U.S. Patent and Trademark Office File a Motion to Dismiss Litigation Over Final Regulations   Sep 21, 09 09:04 ET GSK Limits Medical Education Funding to Independent Programs With Highest Impact on Patient Care   Sep 16, 09 10:00 ET GSK Makes it Easier for Unemployed, Uninsured to Get Free Medicines   Sep 09, 09 15:53 ET FDA Advisory Committee Makes Favorable Recommendation for Cervarix, GlaxoSmithKline's Candidate Cervical Cancer Vaccine   Aug 24, 09 16:30 ET GSK Advisory: Warehouse Theft   Jul 22, 09 11:23 ET GlaxoSmithKline Completes Acquisition of Stiefel   Jul 16, 09 16:38 ET GSK to Announce Q2 Results July 22, 2009   Jul 07, 09 08:00 ET Landmark Study for GSK's Cervical Cancer Vaccine Published in The Lancet   Jun 16, 09 15:11 ET GlaxoSmithKline 13th Annual IMPACT Awards Seek Nonprofits Providing Access to Healthcare   May 12, 09 08:23 ET GSK Extends Strategic Collaboration with Aspen   May 06, 09 06:00 ET GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million   May 01, 09 15:46 ET GlaxoSmithKline Update: Influenza A (H1N1)   Apr 21, 09 13:22 ET GSK Notice of First Quarter 2009 Financial Results Announcement and Teleconference   Apr 20, 09 07:00 ET GlaxoSmithKline and Stiefel to Create New World-Leading Specialist Dermatology Business   Apr 16, 09 08:21 ET GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company   Apr 01, 09 09:00 ET GSK Submits TYVERB(R)/TYKERB(R) (lapatinib) for First-Line Treatment of Metastatic Breast Cancer in Europe, US   Mar 31, 09 02:05 ET GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder   Mar 30, 09 09:14 ET CERVARIX(R) U.S. Regulatory Update   Mar 02, 09 11:47 ET Ample Supplies of Relenza Available as Flu Season Peaks   Feb 17, 09 09:11 ET GSK Initiates Phase III Programme for Novel Type 2 Diabetes Medication, Syncria(R) (albiglutide)   Jan 29, 09 16:31 ET GSK Notice of Full Year Financial Results Announcement   Jan 19, 09 11:49 ET GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding   Jan 09, 09 08:30 ET GSK and XenoPort Resubmit New Drug Application for Solzira(TM) in Restless Legs Syndrome   Jan 07, 09 08:50 ET GlaxoSmithKline Successfully Completes Tender Offer for Shares of Genelabs Technologies, Inc.   Dec 30, 08 08:50 ET GlaxoSmithKline Reduces Minimum Tender Condition and Extends Tender Offer To Acquire Genelabs Technologies, Inc.   Dec 23, 08 16:05 ET Cytokinetics Retains Development and Commercialization Rights to Ispinesib and SB-743921   Dec 15, 08 09:00 ET GlaxoSmithKline Further Extends Tender Offer to Acquire Genelabs Technologies, Inc.   Dec 08, 08 11:25 ET Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa   09:11 ET GlaxoSmithKline Extends Tender Offer for Genelabs Technologies, Inc.   Dec 04, 08 19:00 ET GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program   Dec 03, 08 16:30 ET GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc.   Nov 12, 08 09:44 ET GlaxoSmithKline Commences Tender Offer to Acquire Genelabs Technologies, Inc.   Oct 29, 08 20:44 ET GlaxoSmithKline to Acquire Genelabs Technologies to Increase Focus on Novel Small Molecule Therapies for Hepatitis C   13:00 ET Study Found That Long Term Use of Advair Diskus(R) 250/50 Did Not Adversely Affect Bone Loss in Patients with COPD   Oct 28, 08 13:30 ET New Research Shows Many Patients with Persistent Cough and Sputum Actually had Airway Obstruction Consistent with COPD   Oct 21, 08 10:11 ET GlaxoSmithKline to Acquire the Leading Dry Mouth Brand, Biotene   Oct 20, 08 10:11 ET GSK Notice of Third Quarter 2008 Results Announcement and Teleconference   Oct 07, 08 20:00 ET LF Elimination Program Treats Over Half Billion People and Protects Millions More From Debilitating Disease   Sep 23, 08 09:52 ET GlaxoSmithKline Named a 2008 100 Best Company by Working Mother Magazine   Sep 09, 08 11:47 ET Ellen Strahlman Appointed Chief Medical Officer at GlaxoSmithKline   Sep 08, 08 09:36 ET GlaxoSmithKline plc -- Directorate Change   Aug 21, 08 09:00 ET GlaxoSmithKline To Post Quarterly US Grants Report   Aug 19, 08 09:00 ET New Study Suggests Increasing Prescription Co-payments for Chronic Diseases May Worsen Health Disparities, Adversely Affect Health   Jul 16, 08 12:43 ET GlaxoSmithKline plc Q2 Results Announcement, Webcast and Telephone Link - Wednesday, July 23, 2008   Jun 30, 08 09:03 ET GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval   Jun 25, 08 15:15 ET GlaxoSmithKline Seeks Nonprofits that Provide Access to Healthcare for the 12th Annual GlaxoSmithKline IMPACT Awards   Jun 20, 08 08:00 ET GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers   Jun 06, 08 07:00 ET GlaxoSmithKline Acquires Sirtris Pharmaceuticals, Inc., a World Leader in Sirtuin Research and Development   Jun 02, 08 08:54 ET GlaxoSmithKline Successfully Completes Tender Offer for Shares of Sirtris Pharmaceuticals   May 22, 08 09:00 ET GlaxoSmithKline Announces $500,000 in Fellowships at Stanford Graduate School of Business   May 13, 08 09:00 ET GlaxoSmithKline Named A Top Employer for Promoting Healthy Lifestyles   May 12, 08 10:00 ET New Study Shows Lowering Co-payments Can Lead to Lower Total Healthcare Costs, Improved Overall Health   May 02, 08 09:00 ET GlaxoSmithKline Commences Tender Offer to Acquire Sirtris Pharmaceuticals   Apr 30, 08 17:37 ET FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD   10:12 ET GSK Announces Changes to Corporate Executive Team   Apr 22, 08 16:37 ET GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in 'Sirtuin' Research and Development   Apr 16, 08 13:31 ET First Quarter 2008 Financial Results Announcement and Teleconference   Apr 08, 08 10:41 ET GlaxoSmithKline Confirms Receipt of FDA Letter on Regulatory Reporting   Mar 19, 08 14:23 ET GSK Charitable Support Valued at $564 Million in 2007   Mar 12, 08 09:00 ET Diabetes Ten City Challenge Collaborative Model Shows Improved Patient Health Across Key Clinical Indicators   Mar 06, 08 11:53 ET GlaxoSmithKline Awards Eight Area Healthcare Nonprofits with $40,000 Each in Funding   Feb 14, 08 09:33 ET GSK Launches New Website to Help Employers Lower Costs and Improve the Health of Workers   Jan 15, 08 09:00 ET Patient Advocacy Leaders and Health Policy Professionals Join Forces to Change the Paradigm for Care   Jan 08, 08 08:53 ET New Study Indicates Decreasing Prescription Copayments Results in Increased Adherence for Patients with Chronic Diseases   Jan 03, 08 09:46 ET GlaxoSmithKline and Theravance Announce Start of Large Phase 2B ICS and LABA Studies for Asthma in the Horizon Program   Dec 17, 07 08:33 ET GlaxoSmithKline Receives FDA 'Complete Response' Letter for Cervical Cancer Vaccine   Dec 13, 07 09:31 ET GlaxoSmithKline Presents Innovative Neuroscience Pipeline   Dec 11, 07 16:00 ET GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes   Dec 07, 07 09:04 ET GlaxoSmithKline Announces Appointments to the Board of Directors   Nov 26, 07 16:02 ET GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.      Nov 14, 07 12:32 ET GSK Revises US Labeling for Avandia(R)   Nov 02, 07 19:55 ET Fabre Kramer Pharmaceuticals Receives Decision From FDA on Gepirone ER for Major Depressive Disorder   Oct 23, 07 08:00 ET GlaxoSmithKline and Tolerx Form Worldwide Collaboration for Development and Commercialization of Novel Medication   Sep 26, 07 11:32 ET Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results   Sep 25, 07 08:25 ET GlaxoSmithKline Named to Working Mother '100 Best Companies' List   Sep 18, 07 09:12 ET GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program   Sep 11, 07 16:00 ET GlaxoSmithKline Responds to JAMA Articles   Aug 28, 07 09:00 ET Practicing What They Preach: GSK Announces Employee Wellness Initiative   Aug 16, 07 13:59 ET GlaxoSmithKline IMPACT Awards Deadline - August 28, 2007   12:59 ET Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs   Aug 14, 07 17:07 ET GlaxoSmithKline Updates Prescribing Information for Avandia   11:00 ET GlaxoSmithKline's Application for Rotarix(R) is Accepted for Review by the FDA   Aug 03, 07 13:04 ET GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSK's Candidate Pre-pandemic Flu Vaccine to Start.   Jul 30, 07 19:37 ET FDA Advisory Panel Votes 22 to 1 for Avandia(R) to Remain Available to Patients in the US   08:31 ET GlaxoSmithKline Presents Avandia Data To FDA   Jul 18, 07 15:02 ET GSK's Cervical Cancer Candidate Vaccine Cervarix(TM) Receives Positive Opinion in Europe for Prevention of Cervical Cancer   Jul 12, 07 09:37 ET GlaxoSmithKline Seeks Nonprofits that Provide Access to Healthcare for 11th Annual GlaxoSmithKline IMPACT Awards   Jun 27, 07 19:01 ET Largest Cervical Cancer Vaccine Efficacy Trial Shows CERVARIX(R) Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types   Jun 13, 07 10:00 ET GlaxoSmithKline to Make Unprecedented Vaccine Donation to WHO Pandemic Flu Stockpile   Jun 06, 07 11:35 ET Statement of Moncef Slaoui, PhD, Chairman Research & Development GlaxoSmithKline   09:59 ET Newly Published Data From Large Study Support Cardiovascular Safety of Avandia (rosiglitazone maleate)   Jun 05, 07 19:51 ET GlaxoSmithKline Response to New England Journal of Medicine Editorials   19:14 ET Statement by Philip Home Chairman of the RECORD study steering committee and Professor of Diabetes Medicine at Newcastle University in England.   15:15 ET Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death   09:00 ET Encouraging Clinical Activity of GSK's Novel Cancer Immunotherapeutic Confirmed in Phase II Study in Patients with Most Common Form of Lung Cancer   May 30, 07 12:35 ET Data Affirms Avandia (Rosiglitazone maleate) Cardiovascular Safety Profile   May 21, 07 17:39 ET GlaxoSmithKline Strongly Defends its Record on Avandia   13:23 ET GlaxoSmithKline Responds to NEJM Article on Avandia   May 08, 07 09:00 ET Fabre-Kramer Refiles Gepirone ER with the FDA for the Treatment of Major Depressive Disorder   Apr 27, 07 17:42 ET FDA Approves Once-Daily Veramyst(TM) (fluticasone furoate) Nasal Spray for Treatment of Seasonal and Year-Round Allergy Symptoms in Adults and Children as Young as Two Years   Apr 18, 07 13:29 ET GlaxoSmithKline plc Notice of First Quarter 2007 Financial Results Announcement and Teleconference - Wednesday, April 25, 2007   Mar 30, 07 01:15 ET GlaxoSmithKline Files Meningococcal Conjugate Vaccine   Mar 29, 07 14:22 ET GlaxoSmithKline Submits Biologics License Application to U.S. Food and Drug Administration for CERVARIX(R)   09:00 ET GlaxoSmithKline Appoints Zhi Hong to Head Infectious-Diseases Research Center   Mar 13, 07 15:25 ET GlaxoSmithKline Announces Expansion of Patient Assistance Program to Include TYKERB(R)   15:20 ET FDA Approves TYKERB(R) (lapatinib) in Combination With Xeloda(R) (capecitabine) for the Treatment of Advanced or Metastatic Breast Cancer in Women Who Have Progressed on Prior Therapy   Mar 05, 07 06:00 ET New Studies Indicate GSK's Pre-Pandemic Influenza Vaccine Can Protect Against Different Strains of H5N1   Feb 22, 07 06:00 ET GlaxoSmithKline and NBPTS Announce $1 Million Endowment to Strengthen Science Education in America's Classrooms   Feb 21, 07 05:11 ET Helping the Sandwich Generation with Medicare Part D   Feb 16, 07 08:30 ET GlaxoSmithKline Successfully Completes Tender Offer for Shares of PRAECIS PHARMACEUTICALS   Feb 15, 07 09:00 ET GlaxoSmithKline Extends Subsequent Offering Period By One Day   Feb 13, 07 08:22 ET GlaxoSmithKline Offers New Tools to Help Patients Get Free Medicines   Feb 07, 07 09:11 ET GlaxoSmithKline Accepts Shares in Tender Offer for Shares of PRAECIS PHARMACEUTICALS and Commences Subsequent Offering Period   Feb 02, 07 12:55 ET GlaxoSmithKline Financial Results Announcement Thursday, February 8, 2007   10:46 ET Valtrex (valacyclovir) - US Patent Litigation Update   Jan 29, 07 08:00 ET GlaxoSmithKline Files Its New Pre-Pandemic Influenza Vaccine in Europe   Jan 17, 07 11:43 ET GlaxoSmithKline Awarded $63 Million HHS Contract for Pandemic Vaccine Research and Development   Jan 09, 07 09:03 ET GlaxoSmithKline Commences Tender Offer to Acquire PRAECIS PHARMACEUTICALS   Dec 19, 06 09:00 ET Adrian Rawcliffe to Lead GlaxoSmithKline's Worldwide Business Development   Dec 08, 06 10:56 ET GlaxoSmithKline to Acquire Domantis for 230 Million Pounds Sterling   Dec 07, 06 09:30 ET GlaxoSmithKline Announces New Patient Assistance Programs for Low-Income Medicare Part D Patients   Nov 30, 06 15:40 ET GlaxoSmithKline plc to Hold Avandia In Focus Webcast   Nov 20, 06 12:09 ET GlaxoSmithKline Awarded HHS Contract   Nov 13, 06 12:30 ET GSK Joins With HHS and CDC to Encourage Flu Vaccinations   12:30 ET GSK Joins With HHS and cdc to Encourage Flu Vaccinations   Nov 11, 06 00:01 ET New Data Show Fewer ER Visits and Hospitalizations Among Asthma Patients Treated With Advair Diskus(R)   00:01 ET New Survey Data Reveal Majority of Asthma Patients Remain Uncontrolled Based on Scores from the Asthma Control Test(TM)   Oct 18, 06 09:00 ET GlaxoSmithKline plc Notice of Third Quarter 2006 Financial Results Announcement and Teleconference   Oct 09, 06 09:26 ET GlaxoSmithKline to Acquire CNS, Inc.   Sep 28, 06 09:00 ET GSK Grants License for Manufacture of Influenza Treatment Zanamivir   Sep 25, 06 13:32 ET GlaxoSmithKline Named to Working Mother Hall of Fame   10:05 ET Embracing the Challenge of Globalization: Boston College Convenes Global HR Executives at Inaugural Summit in London Co-Sponsored by GlaxoSmithKline and IBM Corporation   Sep 11, 06 10:34 ET GSK Settles Transfer Pricing Tax Dispute with IRS   Jul 26, 06 02:55 ET GSK Reports Significant Advance in H5N1 Pandemic Flu Vaccine Program   Jul 24, 06 10:52 ET GlaxoSmithKline plc Notice of Second Quarter 2006 Financial Results Announcement and Teleconference   Jul 20, 06 10:06 ET GSK Announces U.S. Government Purchase of Relenza(R) for State Stockpiles   May 24, 06 12:25 ET GlaxoSmithKline Reports on Data Transparency   07:08 ET GlaxoSmithKline Demonstrates Progress of Oncology Portfolio; New Data to Be Presented at ASCO 2006   May 11, 06 15:18 ET GlaxoSmithKline Announces Transitional Plan for Former Patient Assistance Program Enrollees   May 10, 06 09:11 ET GSK Wins World Business Award for Efforts to End Lymphatic Filariasis   May 04, 06 11:17 ET GlaxoSmithKline Awarded $274 Million HHS Contract; Company to Accelerate Cell Culture Influenza Vaccines Development   May 02, 06 10:43 ET GlaxoSmithKline to Continue Patient Assistance Benefits to the Elderly and Disabled Not Enrolled in Medicare Part D   Apr 03, 06 09:27 ET GlaxoSmithKline Receives Positive Data and Halts Enrollment in Phase III Trial of Tykerb(R) (lapatinib) in Advanced Breast Cancer   Mar 30, 06 03:00 ET GlaxoSmithKline Initiates Human Trial Program With Two H5N1 Pandemic Flu Vaccines   Mar 28, 06 06:10 ET GSK Announces Positive Results of Seretide Survival Study In Patients With Chronic Obstructive Pulmonary Disease (COPD)   Mar 23, 06 19:01 ET New Data in Lancet Confirm Potential to Eliminate Lymphatic Filariasis   11:43 ET GlaxoSmithKline Submits Biologics License Application for FDA Approval of FluLaval(TM)   Mar 22, 06 12:01 ET GlaxoSmithKline Begins Testing New Technology to Protect Patients Against Counterfeit Medicine   Mar 21, 06 09:06 ET Patrick Vallance to Head Drug Discovery at GlaxoSmithKline   Mar 13, 06 11:41 ET GlaxoSmithKline Joins Combined White House, Industry, UN Agencies Effort to Fight Pediatric AIDS in Developing Countries   Mar 01, 06 10:02 ET New Study Shows Ohioans Needlessly Suffer Because They Are Not Properly Caring for Chronic Conditions   Feb 21, 06 10:13 ET GlaxoSmithKline Supports the Establishment of `Improving Health for Ohioans' Month   Feb 06, 06 15:21 ET GlaxoSmithKline plc Notice of Year End Financial Results Announcement and Teleconference   09:20 ET Dr. Moncef Slaoui to Head GlaxoSmithKline Research and Development   09:19 ET Dr. Tachi Yamada to Retire; Dr. Moncef Slaoui Appointed Successor as Chairman of GlaxoSmithKline R&D   Jan 17, 06 11:00 ET Global Workforce Roundtable -- International Employer Forum for Discussion of Workforce Strategies -- Is Launched by Boston College Center for Work & Family   Dec 21, 05 11:22 ET GlaxoSmithKline Donates $1 Million to Rebuilding Efforts in South Asia   Dec 08, 05 09:29 ET GlaxoSmithKline Acquires Influenza Vaccine Manufacturer ID Biomedical Corporation   Nov 30, 05 08:07 ET GlaxoSmithKline Presents Rapidly Expanding Pipeline of Oncology and Supportive Care Compounds   Nov 16, 05 12:34 ET GlaxoSmithKline and the Congressional Black Caucus Foundation Join Forces to Improve Opportunities for Small Disadvantaged Businesses   Nov 15, 05 13:43 ET GlaxoSmithKline Has Fifth Offering Certified by NCQA in Disease Management Content and Program Design: Diabetes S.E.T. for Success(R)   10:30 ET GlaxoSmithKline is First Company Certified By NCQA in Program Design for Medication Adherence   Nov 02, 05 15:30 ET GlaxoSmithKline Underlines Commitment to Neglected Diseases With New Manufacturing Investment in Africa   Oct 20, 05 15:12 ET GlaxoSmithKline Biologicals and Aeras Global TB Vaccine Foundation Partner to Develop New TB Vaccine   Oct 19, 05 21:00 ET GlaxoSmithKline Initiates New HIV/AIDS Collaboration in Kenya   Oct 07, 05 17:18 ET GlaxoSmithKline CEO Meets with President Bush to Discuss Pandemic Flu Plans   Sep 22, 05 08:03 ET GSK Scores 100% on Corporate Equality Index   Sep 07, 05 10:31 ET GlaxoSmithKline To Acquire ID Biomedical Corporation   Sep 01, 05 16:21 ET GlaxoSmithKline Aids Hurricane Relief Efforts; One Million Dollars and Health Care Products Donated   14:35 ET `Value of Medicines Awareness Month' Public Education Campaign Launched in Missouri   10:51 ET GlaxoSmithKline Acquires Vaccine R&D and Manufacturing Plant in the US   Aug 31, 05 11:59 ET GlaxoSmithKline Announces FDA Approval of FLUARIX(TM)   Jul 27, 05 17:38 ET GlaxoSmithKline plc Notice of Second Quarter 2005 Financial Results Announcement and Teleconference   Jun 30, 05 07:36 ET GlaxoSmithKline Reviews Pipeline of Novel Vaccines with the Potential to Dramatically Improve Global Health   Jun 27, 05 09:08 ET GlaxoSmithKline Announces Resupply of Paxil CR to US Market   Jun 21, 05 05:30 ET GSK Biologicals and IAVI Partner to Develop AIDS Vaccine   Jun 20, 05 08:30 ET GlaxoSmithKline and Vitae Pharmaceuticals Establish Strategic Alliance to Develop and Commercialize Novel Hypertension Treatment   Jun 13, 05 14:40 ET Acclaimed Singer And 'Touched By An Angel' Star Della Reese Continues Her Crusade to Encourage Others To Be Stronger Than Diabetes   Apr 29, 05 17:21 ET GlaxoSmithKline to Acquire Corixa Corporation - Developer of Novel Vaccine Adjuvants and Antigens   Apr 28, 05 02:09 ET GlaxoSmithKline and FDA Reach Agreement on Consent Decree Regarding Cidra, Puerto Rico, Manufacturing Site   Apr 07, 05 15:56 ET GlaxoSmithKline Issues Statement On the Release of the Center for Global Development's New Report, 'Making Markets for Vaccines: Ideas to Action.'   Mar 04, 05 11:42 ET GSK Announces Disruption of Supply for Paxil CR and Avandamet   Feb 08, 05 12:20 ET The Risk of Both Stroke and Coronary Heart Disease (CHD) Nearly Doubles With Elevated Lp-PLA2 Activity   10:53 ET GlaxoSmithKline plc: Notice of Annual 2004 Results Announcement and Presentation   Jan 26, 05 12:33 ET GSK Receives Notice from IRS on Tax Allocation Dispute for 1997-2000   Jan 04, 05 12:27 ET GlaxoSmithKline Response to Tsunami Disaster - Update   Dec 07, 04 11:01 ET GlaxoSmithKline to Provide Up to 4 Million Emergency Doses of Flu Vaccine to US Market   Nov 23, 04 08:20 ET GlaxoSmithKline Reviews Novel Therapeutics for CNS Disorders and Confirms Strong Pipeline Momentum   Nov 15, 04 11:55 ET GlaxoSmithKline Announces Drug Tracking Effort to Support FDA Battle Against Counterfeit Drugs   Oct 14, 04 18:30 ET Public-Private Partnership Leads to Scientific Breakthrough in Malaria Vaccine Development   Sep 01, 04 09:05 ET GlaxoSmithKline Posts Data on Clinical Trial Register   Aug 26, 04 11:22 ET GlaxoSmithKline Settles Litigation with New York Attorney General's Office   Jul 12, 04 10:14 ET GlaxoSmithKline and Boehringer Ingelheim to Develop Co-Package of Combivir(R) and Viramune(R) for the Developing World   Jul 08, 04 14:03 ET GlaxoSmithKline Agrees to Settle Augmentin Anti-trust Litigation   Jun 18, 04 09:00 ET GlaxoSmithKline Announces Major Advance in On-Line Access to Clinical-Trial Information   Jun 10, 04 12:33 ET GlaxoSmithKline Clarifies Availability of Clinical Trial Data on Paroxetine in Adolescent and Paediatric Patients   Jun 06, 04 18:00 ET New Data Show Avandia(R) (Rosiglitazone Maleate) May Reduce Risk for Type 2 Diabetes and Cardiovascular Disease in African Americans and Hispanic Americans   Jun 02, 04 13:11 ET GlaxoSmithKline Issues Statement in Response to a Lawsuit Filed Today by New York Attorney General Elliot Spitzer   12:04 ET GlaxoSmithKline Recognizes Diversity Initiatives   May 16, 04 11:15 ET GlaxoSmithKline and Boehringer Ingelheim Agree to Assess the Development of Important HIV Medicines for the Developing World   May 07, 04 18:21 ET GlaxoSmithKline Responds to Minnesota Judge's Ruling on Documents   May 04, 04 12:00 ET New Study Shows Controlled-Release Paroxetine Is Associated With a Significant Reduction in Symptoms and Is Generally Well-Tolerated in Fibromyalgia Patients   09:03 ET American Football Hero Terry Bradshaw Takes to the Road   Mar 31, 04 04:00 ET GlaxoSmithKline and Theravance to Form Strategic Alliance   Mar 26, 04 10:04 ET Acclaimed Singer and 'Touched By An Angel' Star Della Reese Urges Boston Residents to Be Stronger Than Diabetes   09:42 ET GlaxoSmithKline Reports On Global Commitment to Corporate Responsibility; Includes Community Investment of 338 Million Pounds Sterling in 2003   Mar 25, 04 15:28 ET GlaxoSmithKline Applauds Launch of CMS Cards; Continues Commitment to the GSK Orange Card   Mar 15, 04 09:58 ET GlaxoSmithKline Launches National Corporate Ad Campaign   Feb 18, 04 12:00 ET GlaxoSmithKline Supports FDA Efforts to Protect Against Counterfeit Drugs   Feb 13, 04 03:30 ET Early Phase Clinical Trial Results Progress GlaxoSmithKline's Investigational CCR5 Antagonist to Next Phase   Feb 11, 04 20:02 ET GlaxoSmithKline Reaffirms Its Position Against a Frivolous Lawsuit Sponsored By the AIDS Healthcare Foundation   Feb 06, 04 07:09 ET GlaxoSmithKline Agrees to Settle Relafen Antitrust Litigation   Feb 05, 04 10:51 ET GlaxoSmithKline plc Notice of Annual 2003 Results Announcement And Presentation   Jan 29, 04 14:14 ET US Court of Appeals Rules in Wellbutrin SR Patent Case   Jan 07, 04 03:12 ET GSK Receives Notice from IRS on Tax Allocation Dispute   Dec 05, 03 09:53 ET GlaxoSmithKline Donates $1.6 Million to African AIDS Clinics   Dec 04, 03 09:02 ET GlaxoSmithKline to Be Cited for Commitment to Tropical Diseases; CEO to Speak at American Society of Tropical Medicines Annual Meeting   Dec 03, 03 03:15 ET GlaxoSmithKline Unveils a Broad R&D Pipeline of Innovative Science and Class-Leading Compounds   Nov 25, 03 16:34 ET GlaxoSmithKline Reinforces Its Commitment to the Orange Card   Nov 21, 03 18:51 ET US Court of Appeals Rules in Augmentin Patent Case   Nov 18, 03 09:05 ET Acclaimed Singer and 'Touched by an Angel' Star Della Reese Urges San Diego Residents to Be Stronger Than Diabetes   Nov 13, 03 11:57 ET Multilaw Award Presented to GlaxoSmithKline   Nov 06, 03 07:01 ET GlaxoSmithKline to Extend New R&D Model With Seventh Center of Excellence for Drug Discovery   Nov 03, 03 09:44 ET Federal Judge Dismisses Claims Against GlaxoSmithKline; FTC Closes Investigation   Oct 16, 03 10:41 ET GlaxoSmithKline Takes Further Action to Help the World's Poorest Fight HIV/AIDS   Oct 13, 03 13:59 ET GlaxoSmithKline plc Notice of Third Quarter 2003 Results Announcement and Teleconference   Sep 04, 03 11:32 ET California Federal Judge Rules in Favor of GSK on Class Certification   Aug 08, 03 03:00 ET Yamanouchi and GlaxoSmithKline Announce U.S. Co-Promotion Agreement on Vesicare(R)(Solifenacin Succinate; YM905), Investigational Compound for the Treatment of Overactive Bladder   Aug 06, 03 02:00 ET MHRA Approves Anti-Malarial Lapdap(TM); New Anti-Malarial Developed Through a Public-Private Collaboration   Jul 25, 03 04:00 ET 10 Million People to Receive Free Medicines on One Day   Jul 14, 03 08:59 ET GlaxoSmithKline plc Notice of Second Quarter 2003 Results Announcement And Teleconference   Jul 10, 03 01:30 ET GlaxoSmithKline Reaches Agreement with Novartis on Augmentin International Trade Commission and State Lawsuits   Jul 09, 03 16:24 ET GSK Offers Financial Aid to State AIDS Drug Assistance Programs   Jul 01, 03 10:14 ET GSK Asks FDA to Remove Three Paxil(R) Patents from Orange Book   Jun 19, 03 18:01 ET GlaxoSmithKline Responds to FDA Talk Paper on Pediatric Data on Paxil   May 20, 03 14:55 ET GlaxoSmithKline and Medivir Announce Licensing Agreement on Antiviral Compound   May 02, 03 11:37 ET GlaxoSmithKline: Federal District Court Upholds Ceftin Patent   Apr 28, 03 02:30 ET GlaxoSmithKline Again Reduces Its Not-For-Profit Price of HIV/AIDS Medicines for the Developing World   Apr 21, 03 12:49 ET GlaxoSmithKline plc Notice of First Quarter 2003 Results Announcement And Teleconference   Apr 18, 03 11:03 ET GlaxoSmithKline, Par Pharmaceutical, Inc. and Pentech Pharmaceuticals, Inc. Agree to Settle Paxil(R) Patent Litigation   Apr 15, 03 10:16 ET GSK Commends CalPERS for Its Support of the Company's Continuing HIV/AIDS Efforts   Mar 28, 03 10:55 ET GSK Confirms Global Commitment to Corporate and Social Responsibility   05:00 ET GlaxoSmithKline and Flamel Technologies Announce License Agreement   Mar 20, 03 08:31 ET Russell Greig to Succeed Howard Pien as President, Pharmaceuticals International, GlaxoSmithKline   Mar 10, 03 15:09 ET California Court Dismisses AIDS Healthcare Foundation Lawsuit   Mar 07, 03 07:03 ET Levitra(TM) (vardenafil HCl) Approved for the Treatment of Erectile Dysfunction by European Commission   Mar 04, 03 08:21 ET Paxil Patent Ruling Issued   Mar 03, 03 14:17 ET FDA Approves Avandia(R) (Rosiglitazone Maleate) for Use in Combination With Insulin For the Treatment of Type 2 Diabetes   Feb 12, 03 07:18 ET /FIRST AND FINAL ADD -- PHW008 -- GlaxoSmithKline plc Results/   07:09 ET Preliminary Announcement of Results for the Year Ended 31st December 2002   Feb 06, 03 10:47 ET Ronald Krall to Join GlaxoSmithKline as Head of Worldwide Development   Feb 04, 03 10:35 ET GlaxoSmithKline plc: Notice of Full Year Results Announcement, Meetings, Webcast and Teleconferences   Jan 23, 03 12:47 ET GlaxoSmithKline Receives Positive Opinion from European Committee for Proprietary Medicinal Products for Seretide(TM) for the Treatment of COPD   Jan 15, 03 02:00 ET GlaxoSmithKline - Paxil Litigation Update; Trial for Hemi-Hydrate Patent Challenge to be Heard 5th February 2003   Jan 06, 03 09:00 ET Theravance and GlaxoSmithKline Form Alliance to Develop Next-Generation Respiratory Medicines   Dec 30, 02 02:00 ET Update on Paxil Patent Litigation   Dec 23, 02 12:51 ET GlaxoSmithKline Consumer Healthcare Adds Rx Dermatology Products to Its Portfolio   Dec 17, 02 03:30 ET GlaxoSmithKline Receives US Approvable Letter for Advair(TM) for the Treatment Of Chronic Obstructive Pulmonary Disease   Dec 09, 02 14:09 ET GlaxoSmithKline Receives European Approval for Avodart(R) for Benign Prostatic Hyperplasia   Nov 22, 02 08:33 ET Levitra(R) Receives Positive Opinion from European Committee for Proprietary Medicinal Products   Nov 21, 02 16:43 ET GlaxoSmithKline Consumer Healthcare Dedicates Headquarters      08:20 ET GlaxoSmithKline Restores Savings on the Orange Card; Company to Offer Refunds to Eligible Orange Card Enrollees   Nov 18, 02 09:39 ET GlaxoSmithKline Announces $1.5 Million in Community Development Grants to Combat Malaria in Africa   Nov 07, 02 08:40 ET GlaxoSmithKline Tyson to Leave; Pulman Appointed President, Global Manufacturing & Supply   Oct 24, 02 11:03 ET GlaxoSmithKline Becomes First Pharmaceutical Company Certified in Disease Management by the National Committee for Quality Assurance   Oct 23, 02 17:35 ET GlaxoSmithKline Restores Savings on Together Rx   07:42 ET Results Announcement For The Third Quarter 2002; GSK Delivers Strong Business Performance with EPS Growth of 15% CER   07:33 ET GlaxoSmithKline and Biovitrum Enter Collaboration On Therapies for Obesity and Other Disorders   04:00 ET GlaxoSmithKline Announces License Agreement with Kissei for Selective Inhibitors of Renal Glucose Transport for Diabetes   Oct 21, 02 09:06 ET James Palmer to Leave GlaxoSmithKline   Oct 15, 02 09:05 ET GlaxoSmithKline's Ingram to Retire; Stout Appointed President, Pharmaceuticals Operations   Oct 14, 02 16:18 ET GlaxoSmithKline plc: Notice of Third Quarter 2002 Results Announcement And Teleconference   Oct 10, 02 18:09 ET California Federal Judge Rules in Favor of GSK on Paxil TV Ads   Sep 26, 02 09:03 ET GlaxoSmithKline Receives FDA Approval for Augmentin XR(TM)Extended Release Tablets   Sep 24, 02 11:38 ET GlaxoSmithKline Named in Working Mother Magazine's 100 Best Companies for Working Mothers   Jul 29, 02 06:01 ET BC Powder Joins SEC Corporate Partner Stable; Analgesic Tabbed `Official Pain Reliever of the SEC'   Jul 24, 02 08:20 ET Results Announcement for the Second Quarter 2002   Jul 19, 02 10:51 ET GlaxoSmithKline plc: Notice of Second Quarter 2002 Results Announcement And Teleconference   Jul 12, 02 10:46 ET GlaxoSmithKline Seeks Nominations for Sixth Annual International IMPACT Awards (US)   Jun 20, 02 12:25 ET GSK Announces Two-Year Price Freeze on HIV/AIDS Medicines   06:01 ET New Data Suggest Potential Long-Term Efficacy of Avandia(R)   Jun 15, 02 18:15 ET New Data Suggest Avandia(R) May Have Positive Effects On Certain Risk Factors For Cardiovascular Disease   12:58 ET Insulin Sensitizer Has Anti-Inflammatory Effect in Diabetics; Study Has Implications For Lowering Heart-Disease Risk in Type 2 Diabetes Patients   May 23, 02 15:58 ET Federal District Court Rules in Augmentin Patent Trial; GSK to Appeal Ruling   May 02, 02 04:01 ET 100 Millionth Treatment Donated in the Battle to Eliminate a Disease   Apr 24, 02 07:46 ET GlaxoSmithKline Results Announcement for the First Quarter 2002   Apr 15, 02 07:30 ET GlaxoSmithKline and Unigene Announce Agreement to Develop Oral Parathyroid Hormone for Osteoporosis   02:00 ET LG Chemical Investments To Regain Worldwide Rights To Commercialize Gemifloxacin   Mar 13, 02 16:17 ET Federal Court Rules in AUGMENTIN Patent Challenge; GSK to Appeal Ruling on Patents Expiring in 2017 and 2018   Mar 05, 02 06:00 ET GlaxoSmithKline Announces US Winners of International Impact Awards   Mar 01, 02 13:19 ET Federal Court Rules in Wellbutrin SR / Zyban Patent Challenge   Feb 14, 02 08:07 ET GlaxoSmithKline Preliminary Announcement of Results for the Year Ended 31st December 2001   Feb 01, 02 14:33 ET GlaxoSmithKline plc Notice of Annual 2001 Results Announcement and Presentation   Jan 31, 02 09:02 ET Start of First Clinical Trial With GlaxoSmithKline Biologicals' Novel HIV Vaccine   Dec 17, 01 07:04 ET Federal Court Rules in Augmentin Patent Challenge   Nov 15, 01 02:30 ET GlaxoSmithKline and Bayer Announce World-wide Co-Promotion Agreement For Vardenafil to Treat Erectile Dysfunction   Oct 23, 01 07:05 ET GlaxoSmithKline Results Announcement for the Third Quarter 2001   Oct 12, 01 17:51 ET GlaxoSmithKline plc Notice of Third Quarter 2001 Results Announcement And Teleconference   Oct 11, 01 09:10 ET GlaxoSmithKline and University of California, San Francisco to Collaborate With Medicines for Malaria Venture on Joint Project   Sep 14, 01 10:05 ET GlaxoSmithKline Donates $1 Million Toward Support for Victims' Families   Sep 11, 01 04:00 ET GSK and Tanabe to Collaborate on Development and Commercialisation Of Preclinical Products   Sep 04, 01 10:48 ET Report by GlaxoSmithKline and Neuromed Scientists Points Way to New Path in Addiction Research   Jul 30, 01 10:38 ET GlaxoSmithKline Divests Affymax Business to Venture Syndicate Led By Patricof & Co. Ventures, Inc.   Jul 24, 01 13:21 ET /FIRST AND FINAL ADD -- PHTU012 -- GlaxoSmithKline Results/   13:19 ET GlaxoSmithKline Results Announcement for the Second Quarter 2001   10:01 ET GlaxoSmithKline Results Announcement for the Second Quarter 2001   04:00 ET GSK and Shionogi to Enter Global Multi-Product Development And Commercialization Alliance; GSK-Shionogi Joint Venture to be Formed   Jul 17, 01 12:16 ET GlaxoSmithKline Seeks Nominations for 2001-2002 Community Health IMPACT Awards   Jul 12, 01 10:42 ET GlaxoSmithKline plc: Notice of Second Quarter 2001 Results Announcement and Teleconferences   Jul 10, 01 14:44 ET GlaxoSmithKline and Taisho Agree Smoking Control Partnership in Japan   Jun 20, 01 11:09 ET Avandia(R) [Rosiglitazone Maleate] Reaches 10 Million Retail Prescription Milestone at Two-Year Anniversary   Jun 14, 01 09:42 ET GlaxoSmithKline Announces Proposals for UK Pharmaceutical Manufacturing Operations and Consumer Manufacturing Operations   Jun 12, 01 08:32 ET New Parkinson's Disease Guidelines Call for Change in Treatment Strategy; Dopamine Agonists Recommended as First Line Treatment   Jun 11, 01 03:00 ET GlaxoSmithKline Reaffirms Commitment to Fight Diseases Of the Developing World   May 24, 01 16:30 ET GlaxoSmithKline's Novel Candidate HIV Vaccine Prevents AIDS in Pre-Clinical Trials   May 21, 01 14:29 ET An Investment For Life: The Value Of Vaccines At All Life Stages   May 14, 01 08:23 ET GlaxoSmithKline's TWINRIX(R), First Combination Hepatitis A & B Vaccine, Approved by FDA   May 07, 01 09:11 ET Three Studies Show Paxil(R) to be the First Effective Medication For Men and Women With Posttraumatic Stress Disorder   08:32 ET Study Data Presented on Requip(R) (ropinirole HCl) As Treatment for Restless Legs Syndrome (RLS)   Apr 29, 01 09:00 ET GlaxoSmithKline Announces Agreement With the Government of Burundi to Increase Access to HIV/AIDS Medicines   Apr 25, 01 11:35 ET Pediatric Clinical Trial for GlaxoSmithKline Malaria Vaccine To Begin Next Month in The Gambia   Apr 24, 01 08:36 ET Results Announcement For The First Quarter 2001   Apr 20, 01 17:59 ET GlaxoSmithKline Notice of First Quarter Results Announcement and Teleconference   Apr 19, 01 12:22 ET GlaxoSmithKline Welcomes the Settlement of Industry Association Litigation Against the South African Government   Apr 09, 01 10:46 ET GlaxoSmithKline Announces Agreement With the Government of Mali to Increase Access to HIV/AIDS Medicines   Apr 06, 01 11:16 ET GAVI and GlaxoSmithKline Deliver First Vaccines to Africa In New Vaccine Initiative for the Developing World   Mar 15, 01 16:44 ET GlaxoSmithKline Selects MediaCom as Media Buying Agency of Record   11:31 ET Major Initiative by GlaxoSmithKline Biologicals Will Save Even More Lives New Auto-Disable Syringe Prevents Re-Use   Mar 02, 01 12:48 ET GlaxoSmithKline and the World Health Organization Sign Agreement to Develop a New Treatment for Malaria   Feb 26, 01 10:32 ET GlaxoSmithKline's Infanrix(R) (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) Captures Majority of DTPa Market   Feb 22, 01 05:53 ET GlaxoSmithKline and Sepsicure in Licensing Agreement on Compound For Treating Sepsis   05:51 ET GlaxoSmithKline Unveils Strategy for Growth   Feb 21, 01 07:05 ET GlaxoSmithKline's Strong Performance from Key Therapy Areas and New Products Drives Earnings Per Share Growth to 16% in Sterling (14% CER)   Feb 15, 01 02:00 ET GlaxoSmithKline and Merck KGaA Sign Worldwide Agreement on Antidepressant   Feb 13, 01 16:44 ET GlaxoSmithKline plc: Notice of Inaugural Investor Meeting UK - Thursday, February 22nd US - Friday, February 23rd   16:37 ET GlaxoSmithKline plc: Notice of Full Year Results Announcement and Teleconference   Feb 09, 01 09:00 ET FDA Issues Approvable Letter for Avandia(R) (Rosiglitazone Maleate) Combination Therapy   Jan 31, 01 10:02 ET FTC Makes Final Its Consent Order to Approve GlaxoSmithKline Merger   Jan 16, 01 09:40 ET GlaxoSmithKline Completes the Purchase of Block Drug for $1.24 Billion   Jan 11, 01 14:02 ET GlaxoSmithKline and Block Drug Receive Regulatory Approval to Complete The Purchase by GlaxoSmithKline of Block Drug for $1.24 Billion   Dec 27, 00 09:10 ET GlaxoSmithKline plc - Commencement of Dealings   Dec 18, 00 07:30 ET Glaxo Wellcome and SmithKline Beecham Merger Update: US Regulatory Clearance Obtained   Dec 15, 00 20:15 ET SmithKline Beecham Receives Non-Approval Letter from the FDA on Factive(R)   Dec 14, 00 08:58 ET SmithKline Beecham Extends its Cash Offer For Block Drug   Dec 12, 00 06:20 ET SmithKline Beecham Terminates Clinical Trial of Lotrafiban   06:19 ET Glaxo Wellcome and SmithKline Beecham Merger Update: Completion Planned for December 27, 2000   Nov 14, 00 07:03 ET SmithKline Beecham Completes Enrollment and Initial Treatment Phase of PRESTO (Prevention of Restenosis with Tranilast and its Outcomes) TRIAL   Nov 13, 00 08:16 ET SmithKline Beecham's Anticoagulant Argatroban is Now Available In the United States   Nov 08, 00 12:28 ET SmithKline Beecham's Avandia(R) to be Used in First Worldwide Study For Prevention of Type 2 Diabetes   Oct 31, 00 09:05 ET Celebrity Chefs Across the Nation Crusade for Diabetes Awareness   07:37 ET /FIRST AND FINAL ADD -- PHTU010 -- SmithKline Beecham Earnings/   07:36 ET SmithKline Beecham Reports Earnings Per Share Increase of 33 Per Cent For Third Quarter 2000, 24 Per Cent Excluding Currency   Oct 25, 00 15:30 ET Data Demonstrate Anticoagulant Benefit of SmithKline's Argatroban In Heparin-Induced Thrombocytopenia (HIT) Patients Undergoing Coronary Procedures   Oct 18, 00 16:55 ET Study in The New England Journal of Medicine Finds Potential New Risk Factor for Heart Attack   Oct 09, 00 06:42 ET SmithKline Beecham to Purchase Block Drug for $1.24 Billion; Acquisition to Expand SB's Presence in Oral Healthcare And Over-the-Counter Medicines (OTCs)   Sep 18, 00 09:46 ET Factive(R) Faster Than Biaxin in Eradicating the Leading Cause of Airway Infections in Patients With Chronic Bronchitis   Sep 14, 00 09:39 ET SmithKline Beecham's Hycamtin(R) Shown to be Active in First-Line Combination Treatment for Advanced Non-Small Cell Lung Cancer   Sep 13, 00 17:24 ET Avandia.com Now Offers Technical Support on Demand   Sep 11, 00 06:20 ET Glaxo Wellcome and SmithKline Beecham Merger Update   Sep 05, 00 10:01 ET SmithKline Beecham Ranked Among Top 100 Companies For Working Mothers by `Working Mother' Magazine   Aug 31, 00 06:12 ET SmithKline Beecham Sells Kytril to Roche, Famvir and Vectavir/Denavir to Novartis   Aug 01, 00 10:28 ET SmithKline Beecham Accepting Applications For Its Community Health IMPACT Awards Program   Jul 26, 00 14:00 ET Study of Fat-Reducing Protein Opens New Path Toward Obesity Treatment   Jul 25, 00 14:36 ET SmithKline Beecham Reports Earnings Per Share Increase of 18 Percent For Second Quarter 2000, 16 Percent Excluding Currency   08:34 ET SmithKline Beecham and Taiho Sign Agreement for New Anti-Cancer Treatment   05:54 ET Glaxo Wellcome and SmithKline Beecham Issue Merger Update   Jul 24, 00 10:33 ET SmithKline Beecham Submits Market Application to FDA for Paxil(R) to Treat PostTraumatic Stress Disorder (PTSD); PTSD Affects Up to 1 Out of 7 Americans   Jul 19, 00 16:21 ET MedImmune Grants SmithKline Beecham an Exclusive Worldwide License to Streptococcus Pneumoniae Vaccine Technology   Jul 05, 00 09:31 ET /FIRST AND FINAL ADD -- PHW011 -- GlaxoSmithKline Merger/   09:29 ET Publication of GlaxoSmithKline Merger Documentation   Jun 30, 00 11:15 ET SmithKline Beecham and Texas Biotechnology Announce Argatroban's Approval For The Prevention or Treatment of Thrombosis in Heparin-Induced Thrombocytopenia   Jun 23, 00 10:01 ET Senior Executive Appointments Announced for Glaxo SmithKline   Jun 21, 00 12:00 ET Avandia(R) Demonstrates Long-Term Blood Sugar Control   Jun 10, 00 13:00 ET SmithKline Beecham's Avandia(R) to Be Used in Department of Veterans Affairs (VA) Landmark Diabetes Study   11:01 ET New Evidence Suggests That Avandia(R) Improves Beta Cell Function in the Pancreas   11:00 ET New Evidence Suggests That Avandia(R) Improves Beta Cell Function in the Pancreas   May 22, 00 09:46 ET A New International `Virtual Library' for All Those Interested in Vaccines And Immunization   May 20, 00 20:05 ET New Phase III Study Continues Positive Results Seen With Hycamtin(R) In First-Relapse Ovarian Cancer   May 19, 00 14:10 ET Avandia Safe and Effective for the Treatment of Type 2 Diabetes   May 17, 00 16:53 ET The New England Journal Of Medicine Publishes Important Parkinson's Disease Study   May 15, 00 11:00 ET Study Results Show Paxil to be Effective in the Treatment of Generalized Anxiety Disorder   May 11, 00 15:48 ET Free Educational Materials Available on SmithKline Beecham Product Web Site   May 10, 00 14:00 ET Hot-Pepper Receptor is a Link in Pain Pathway, SB Scientists Learn in `Knock-Out' Study   08:11 ET Glaxo Wellcome and SmithKline Beecham Announce Consolidation of Management, Commercial and Administrative Sites in South-east England from Ten Sites To Three for the Combined Glaxo SmithKline plc   May 08, 00 13:26 ET European Commission Approves Merger of Glaxo Wellcome and SmithKline Beecham   May 01, 00 09:01 ET SmithKline Beecham Submits Market Application to FDA For Paxil(R) to Treat Generalized Anxiety Disorder (GAD)   Apr 28, 00 09:01 ET JP Garnier Becomes Chief Executive of SmithKline Beecham; Jan Leschly Retires   Apr 20, 00 07:36 ET SmithKline Beecham Reports Earnings Per Share Increase of 15 Percent For First Quarter 2000, 16 Percent Excluding Currency   Apr 03, 00 15:28 ET SmithKline Beecham's Avandia(R) Approved by the FDA for the Treatment Of Type 2 Diabetes in Combination With Sulfonylureas   Mar 21, 00 08:32 ET Major Heart Failure Trial Stopped Due to Significant Survival Benefit; COREG(R) (carvedilol) Demonstrates Mortality Benefit in Advanced Heart Failure   Mar 16, 00 11:26 ET SmithKline Beecham Achieves Positive Outcome for Avandia(R) in Europe   Mar 02, 00 09:02 ET SmithKline Beecham Supports President's Millennium Vaccine Initiative By Announcing Pediatric Trial of Malaria Vaccine and Renews Pledge To Donate $1 Billion to Eliminate Lymphatic Filariasis   Feb 29, 00 13:05 ET New Study Shows Positive Results Using Hycamtin(R) As Salvage Therapy For Patients With Recurrent Ovarian Cancer   Feb 22, 00 13:00 ET SmithKline Beecham Announces Winners of Third Annual Community Health Impact Awards   Feb 16, 00 07:39 ET /SECOND AND FINAL ADD -- PHW008 -- SMITHKLINE NOTES/   07:36 ET /FIRST ADD -- PHW008 -- SMITHKLINE EARNINGS/   07:34 ET SmithKline Beecham Reports 1999 Results: Earnings Per Share Increase 15 Percent, 13 Percent Excluding Currency   02:30 ET SmithKline Beecham and Asahi Chemical Sign Agreement For Obesity and Diabetes Compounds   Feb 03, 00 09:07 ET Glaxo SmithKline Executive Team Announced   Feb 02, 00 08:05 ET Investment Management Teams of S.R. One, Limited and Euclid Partners Announce New Fund   Jan 31, 00 09:23 ET Largest Trial Ever in Preventing Restenosis Will Study Tranilast For SmithKline Beecham   Jan 26, 00 14:00 ET Gene Inhibiting Regeneration of Nerve Cells Is Identified By SmithKline Beecham Scientists   Jan 19, 00 08:05 ET Coley Pharmaceutical Group and SmithKline Beecham Sign Collaboration   Jan 17, 00 02:50 ET /FIRST AND FINAL ADD -- Proposed Merger of Glaxo Wellcome, SmithKline Beecham/   02:21 ET Proposed Merger of Glaxo Wellcome and SmithKline Beecham Creating the Global Leader in Pharmaceuticals   02:18 ET Proposed Merger of Glaxo Wellcome and SmithKline Beecham Creating the Global Leader in Pharmaceuticals   Jan 05, 00 16:49 ET Avandia(R) (Rosiglitazone Maleate) Reaches One Million Retail Prescription Milestone   11:53 ET Avandia (Rosiglitazone Maleate) Reaches One Million Retail Prescription Milestone   Dec 20, 99 09:34 ET Avandia.com Simulates Insulin Resistance in People with Type 2 Diabetes   Dec 15, 99 08:01 ET SmithKline Beecham Submits Market Application to FDA For New Antibiotic to Treat Respiratory Tract Infections   Dec 14, 99 09:04 ET FDA Confirms Role of Hepatitis B Vaccine in Helping to Prevent Chronic Hepatitis B Infection Which Can Lead to Primary Liver Cancer   Dec 02, 99 08:28 ET Leschly to Retire in April 2000; Garnier to Succeed Him As Chief Executive of SmithKline Beecham   Nov 19, 99 10:27 ET Data Show LYMErix(R) Is Well Tolerated in Children and Is Effective Against Asymptomatic Infection in Adults   Nov 04, 99 09:00 ET Landmark Type 2 Diabetes Study to Examine Effects of Early Treatment With Avandia(R) (Rosiglitazone Maleate) on Disease Progression; Worldwide, 4-Year Study to Enroll More Than 3,500 Newly Diagnosed Patients   Nov 03, 99 10:03 ET SmithKline Beecham Awards Three-Year, $300,000 Grant to the Carter Center; Funds to Support Rosalynn Carter Fellowships for Mental Health Journalism   Oct 29, 99 13:00 ET SmithKline Beecham Dedicates New Office Building In Philadelphia; First Major Center City Office Project in 10 Years   Oct 28, 99 14:21 ET Enzyme Implicated in Alzheimer Disease Is Identified by SmithKline Beecham Scientists; Finding Provides New Target for Drug Discovery   07:38 ET George Poste to Retire from SmithKline Beecham; Chief Science and Technology Officer Leaves at Year-End   Oct 21, 99 08:04 ET SmithKline Beecham: European Committee Opinion on Avandia(R)   08:00 ET /FIRST AND FINAL ADD -- PHTH010 -- SMITHKLINE BEECHAM EARNINGS/   07:56 ET SmithKline Beecham Reports Earnings Per Share Increase Of 15 Percent for Third Quarter 1999, 11 Percent Excluding Currency   Oct 12, 99 14:00 ET New Study Shows Ariflo(R), SmithKline Beecham's Investigational PDE4 Inhibitor, Improved Pulmonary Function in Chronic Obstructive Pulmonary Disease (COPD)   Sep 30, 99 09:21 ET SmithKline Beecham to Donate $860,000 to Ovarian Cancer National Alliance; Three-Year Project Focused on Increasing Public Awareness and Early Detection   Sep 29, 99 21:33 ET New Studies Show SmithKline Beecham's Gemifloxacin More Potent Than Other Quinolones And Demonstrates Activity Against Resistant Bacteria   Sep 28, 99 14:00 ET SmithKline Beecham Announces Results of its Phase III Study on Twinrix(TM), First Combination Hepatitis A/B Vaccine   Sep 15, 99 14:00 ET SmithKline Beecham Scientists Identify Receptor For Potent Vasoconstricting Hormone   Sep 13, 99 07:21 ET SmithKline Beecham and SkyePharma Sign Agreement to Develop Once-Daily Requip   Aug 16, 99 14:50 ET SmithKline Beecham Completes Sale of SmithKline Beecham Clinical Laboratories To Quest Diagnostics   Jul 30, 99 10:30 ET Sir Ian Prosser Appointed to SmithKline Beecham Board of Directors   Jul 29, 99 09:10 ET SmithKline Beecham and the Finlay Institute of Cuba Reach Agreement On Vaccine Against Bacterial Meningitis   Jul 28, 99 17:42 ET SmithKline Beecham's Kytril(R) Tablets Approved for the Prevention of Radiation-Induced Nausea and Vomiting   Jul 26, 99 09:00 ET New Study Shows Early Treatment with Parkinson's Drug Requip(R) Significantly Reduces the Risk of Dyskinesias and Is Effective Long-Term   Jul 22, 99 09:00 ET SmithKline Beecham Celebrates 10th Anniversary With Employee Volunteer Effort   Jul 20, 99 07:35 ET /FIRST AND FINAL ADD -- PHTU011 -- SMITHKLINE BEECHAM EARNINGS/   07:33 ET SmithKline Beecham Reports Earnings Per Share Increase of 16 Percent for Second Quarter 1999, 15 Percent Excluding Currency   Jul 15, 99 08:42 ET SmithKline Beecham Submits Market Application to FDA for Vaccine Against Five Childhood Diseases   Jul 12, 99 14:53 ET New Amoxil(R) (Amoxicillin) With Improved Dosing Regimen Now Available for Pediatric Patients   Jul 05, 99 07:30 ET SmithKline Beecham and Groupe Fournier Sign Agreement for New Antithrombotic   Jun 21, 99 00:01 ET New Era in Type 2 Diabetes Management: Avandia(R) Only TZD Indicated For Initial Monotherapy and in Combination With Metformin   Jun 14, 99 16:00 ET Avandia(R) is Powerful Insulin Sensitizer; Studies also Provide Estimates of Beta-Cell Function   Jun 11, 99 12:09 ET SmithKline Beecham's Avandia Is Now Available In More Than 40,000 Pharmacies Nationwide   Jun 02, 99 06:59 ET New Study Shows Women Can Prevent Bone Loss With Lower Dose HRT And Calcium   May 25, 99 18:38 ET SmithKline Beecham's Avandia(R) Approved by FDA For the Treatment of Type 2 Diabetes   May 19, 99 18:19 ET Three Hycamtin(R) Studies Show Positive Results in First-Line Combination Therapy for Extensive Small Cell Lung Cancer   May 18, 99 09:00 ET Three Hycamtin(R) Studies Show Positive Results in First-Line Combination Therapy for Extensive Small Cell Lung Cancer   May 17, 99 08:01 ET Hycamtin(R) Shows Positive Study Results in First-Line Combination Therapy For Patients With Ovarian Cancer   May 12, 99 10:00 ET SmithKline Beecham Honors Hennepin County Medical Center Systems; Glenwood-Lyndale Community Clinic a Finalist for National Award   May 11, 99 13:37 ET First Medication for the Treatment of Social Anxiety Disorder Approved by the FDA   May 04, 99 16:30 ET SmithKline Beecham's Augmentin(R) Demonstrated More Effective Than Zithromax(R) in Eradicating Key Bacteria That Cause Middle Ear Infections   Apr 23, 99 08:10 ET SmithKline Beecham Announces U.S. Co-Promotion Agreement With Bristol-Myers Squibb for Avandia(R)   Apr 20, 99 07:38 ET SmithKline Beecham Reports Earnings Per Share Increase of 15 Percent for First Quarter 1999, 13 Percent Excluding Currency   Apr 19, 99 10:55 ET SmithKline Beecham's Bactroban(R) Nasal Shown to Decrease Risk of S. Aureus Nosocomial Infections in Surgical Patients   Apr 16, 99 09:38 ET New Amoxil(R) (Amoxicillin) With Improved Dosing Regimen Receives FDA Approval for Pediatric Patients   Apr 12, 99 11:11 ET Santa Clara Family Health Plan Wins National Award from SmithKline Beecham; Community Efforts Providing Low-Income Health Care Win $50,000   Apr 01, 99 12:50 ET SmithKline Beecham Completes Sale of Diversified to Express Scripts   Mar 25, 99 14:26 ET Diversified's New Reporting Tool Diagnoses Drug Trend; On-Line Tool Prioritizes Pharmacy Costs According to Greatest Financial Impact   Mar 19, 99 08:00 ET SmithKline Beecham Recognizes New Research by Oncology Fellows in Third-Annual Forum; Eight Medical and Gynecologic Oncology Fellows Win Grants   Mar 18, 99 09:32 ET Diversified's Overall Drug Trend Less Than Half Industry Average; Management Process Continues to Help Clients Control Costs   Mar 02, 99 12:23 ET Results of a New Study in Movement Disorders Show SmithKline Beecham's Requip(R) Relieves Symptoms of Restless Legs Syndrome   Feb 17, 99 10:01 ET SmithKline Beecham Announces Winners of Second Annual Community Health Impact Awards   Feb 10, 99 07:00 ET SmithKline Beecham Names Yamada Chairman R&D, Pharmaceuticals; U'Prichard Announces Resignation   Feb 09, 99 06:07 ET SmithKline Beecham Forecasts Mid- To High-Teens Earnings Growth   Jan 21, 99 09:33 ET U.S. Food And Drug Administration Grants Priority Review To SmithKline Beecham's Avandia(TM) For Type 2 Diabetes   Jan 14, 99 14:23 ET Diversified Signs Contract with Oxford for Pharmacy Benefit Management Services, Covers 2 Million Members   Jan 12, 99 09:28 ET LYMErix(TM) - World's First Lyme Disease Vaccine Now Available From SmithKline Beecham   Dec 23, 98 09:13 ET SmithKline Beecham Announces Delay of Initiation of Phase IIB Studies of Anti-CD4 Immunotherapy   Dec 21, 98 13:21 ET First Lyme Disease Vaccine LYMErix(TM) Approved by FDA; SmithKline Beecham to Make New Vaccine Available Shortly   Dec 14, 98 09:33 ET SmithKline Beecham and Ribi Announce Positive Hepatitis B Phase III Trial Data   Dec 04, 98 09:00 ET Andrew Bonfield Appointed to SmithKline Beecham Board of Directors   Dec 03, 98 11:08 ET SmithKline Beecham's Hycamtin(R) Approved for Use as Second-Line Treatment of Small Cell Lung Cancer   09:36 ET SmithKline Beecham Submits Application to European Regulatory Authorities To Market Avandia(TM) for the Treatment of Type 2 Diabetes   Nov 30, 98 10:48 ET SmithKline Beecham Submits Application to U.S. FDA For Avandia(TM) For the Treatment of Type 2 Diabetes   Nov 23, 98 09:00 ET SmithKline Beecham Consumer Health Care Launches NiQuitin CQ in Europe   Nov 05, 98 10:00 ET New SmithKline Beecham Web Site for Information Technology Professionals   Oct 28, 98 13:00 ET Study Shows SmithKline Beecham's Kytril(R) Tablets Prevent Nausea and Vomiting In Cancer Patients Undergoing Abdominal Radiation   Oct 21, 98 09:44 ET Study Recently Published in Neurology Shows SmithKline Beecham's Requip(R) Effective for Early to Late-Stage Parkinson's Disease   Oct 20, 98 07:35 ET SmithKline Beecham Reports Third Quarter 1998 Results; Performance Driven By Increased Volume And Continued New Product Momentum   Oct 12, 98 11:19 ET SmithKline Beecham Wins Cimetidine Patent Suit Against Fujimoto Pharmaceutical   Oct 08, 98 09:01 ET SmithKline Beecham's Seroxat(R)/Paxil(R) Approved In United Kingdom To Treat Social Anxiety Disorder   Oct 01, 98 11:00 ET SmithKline Beecham Announces Laboratory Services Agreement With Aetna U.S. Healthcare   Sep 30, 98 10:00 ET Magee Rehabilitation, Penn State, the Pennsylvania Department of Aging And SmithKline Beecham Collaborate on Study to Help the Elderly Manage Medication Safely   Sep 28, 98 09:10 ET SmithKline Beecham Makes Strategic Investment in Romania   Sep 27, 98 08:30 ET New Study Results for LYMErix(TM) Demonstrate Flexible Dosing Schedule   Sep 10, 98 08:01 ET SmithKline Beecham Names Andrew Bonfield Chief Financial Officer; Hugh Collum to Retire   Aug 13, 98 10:00 ET SmithKline Beecham's Engerix-B Vaccine Approved For Use in Patients With Chronic Hepatitis C Infection   Aug 12, 98 09:00 ET SmithKline Beecham Supports New Chair in Biostatistics at London School of Hygiene & Tropical Medicine   Jul 21, 98 07:29 ET SmithKline Beecham Reports Second Quarter 1998 Results; Performance Driven By Continued New Product Momentum   Jul 14, 98 10:00 ET New Amoxil (Amoxicillin) with Improved Dosing Regimens Receives FDA Approval   Jul 01, 98 10:00 ET SmithKline Beecham Announces 1998 Community Health Impact Awards Program; Ten Philadelphia Area Healthcare Organizations to Receive $40,000 Each   Jun 16, 98 09:38 ET SmithKline Beecham's Famvir(R) First and Only Oral Drug Approved by the FDA for Treatment of Herpes in People With HIV   Jun 11, 98 10:02 ET Arizona Physicians Wins National Award from SmithKline Beecham; APIPA Kid's Clothes Swap Meet Wins $50,000   May 26, 98 19:18 ET SmithKline Beecham's LYMErix(TM) Found Safe and Effective For Prevention of Lyme Disease By FDA Advisory Committee   May 21, 98 02:00 ET SmithKline Beecham to File Lawsuit to Prevent Infringement Of Paxil(TM) Patent in United States   May 18, 98 10:36 ET SmithKline Beecham and LEO Pharmaceutical Products Enter Collaboration in Dermatology   May 15, 98 08:30 ET SmithKline Beecham Announces Executive Appointments   May 07, 98 10:00 ET SmithKline Beecham Announces Expansion to New Office Building in Philadelphia   Apr 21, 98 07:36 ET SmithKline Beecham Reports First Quarter 1998 Results: Strong Underlying Performance Driven By Continued New Product Momentum   Apr 14, 98 08:31 ET SmithKline Beecham's Expanding Portfolio of Drugs and Vaccines - `Deep, Diversified and Innovative'   Mar 17, 98 11:00 ET An Additional Quarter Of A Million Smokers Quit Each Year Due To Increased Access To Proven Therapies   Mar 02, 98 11:02 ET IDEC Pharmaceuticals and SmithKline Beecham Announce Future Direction for Joint Anti-CD4 Development Program   Feb 25, 98 09:00 ET Medicare Now Reimburses All Cancer Patients for Kytril Tablets To Prevent Chemotherapy-Induced Nausea and Vomiting   Feb 23, 98 17:46 ET SmithKline Beecham plc Termination of Merger Discussions   Feb 20, 98 09:00 ET Hycamtin(R) Shows Activity in Multiple Myeloma; Encouraging Results Seen in Treatment of Bone Marrow Cancer   Feb 17, 98 07:39 ET SmithKline Beecham Reports 1997 Results: New Products Continue To Drive Strong Underlying Growth   Feb 06, 98 12:00 ET SmithKline Beecham Announces Winners of Community Health Impact Awards; Ten Philadelphia Area Healthcare Organizations Receive $40,000 Each   Feb 02, 98 09:01 ET Study Shows Single Dose of Kytril(R) Tablets Controls Chemotherapy-Induced Nausea And Vomiting as Effectively as Intravenous Ondansetron   Jan 30, 98 18:02 ET Glaxo Wellcome plc and SmithKline Beecham plc Announcement of Merger Discussions   18:00 ET SmithKline Beecham plc Termination of Merger Talks   Jan 26, 98 06:00 ET SmithKline Beecham and the World Health Organization to Collaborate In Seeking to Eliminate One of the World's Greatest Scourges -- Lymphatic Filariasis (Elephantiasis)   Jan 20, 98 06:24 ET Smithkline Beecham Issues Statement   Jan 12, 98 09:00 ET SmithKline Beecham's Timentin(R) Is Cleared for Use in Pediatric Patients   Dec 23, 97 11:05 ET SmithKline Beecham's Teveten Cleared for Hypertension   Dec 18, 97 09:42 ET Cold And Flu Care, Games, Contests and Rebates Are Focus Of Smithkline Beecham Web Site   Dec 15, 97 09:00 ET SmithKline Beecham's Bactroban Cream for Secondarily Infected Traumatic Skin Lesions Cleared by FDA   Dec 09, 97 18:00 ET Hycamtin Shows Promising Results as Combination Therapy In Patients With Leukemia   Dec 04, 97 02:30 ET SmithKline Beecham Names Howard Pien President, Pharmaceuticals-North America   Nov 05, 97 09:00 ET SmithKline Beecham's Kytril(R) Tablets Receive FDA Clearance For Once-Daily Dosing   Oct 21, 97 07:39 ET SmithKline Beecham Reports Third Quarter 1997 Results: Strong Underlying Performance Driven By Continued New Product Growth   Sep 22, 97 15:34 ET New Parkinson's Disease Drug Requip(TM) from SmithKline Beecham Cleared for Use by FDA   07:59 ET SmithKline Beecham Clinical Laboratories and Progenitor Announce Exclusive Licensing Agreement on Genetic Test for Iron Overload Disease   Sep 16, 97 16:51 ET SmithKline Beecham's Famvir(R) Receives FDA Clearance for Suppression Of Recurrent Genital Herpes   Sep 15, 97 10:30 ET SmithKline Beecham Announces Community Health Impact Awards Program; Ten Philadelphia Area Organizations to Receive $40,000 Each   Sep 10, 97 10:46 ET SmithKline Beecham Co-Sponsors PBS Telecast: `A Question Of Genes: Inherited Risks'   Sep 08, 97 10:30 ET SmithKline Beecham Announces Plans for New Office Building in Philadelphia; Office Development in London Also Moving Forward   Aug 26, 97 16:12 ET SmithKline Beecham Stock Split   Aug 20, 97 08:55 ET SmithKline Beecham's Proposed Stock Split Passed With an Overwhelming Majority   Aug 15, 97 13:13 ET SmithKline Beecham Donates Vital Vaccine to Children of Flood Areas in Eastern Europe; Havrix(TM) to Be Rushed to Poland and the Czech Republic This Week to Prevent Outbreaks of Hepatitis A Virus Due to Contaminated Water Supplies   Aug 13, 97 09:10 ET SmithKline Beecham Appoints Dr. David C. U'Prichard Chairman, Research And Development, Pharmaceuticals   Jul 29, 97 09:59 ET SmithKline Beecham Files With the FDA for the Use of Famvir(R) in Immunocompromised Patients   Jul 22, 97 07:40 ET SmithKline Beecham Reports Second Quarter 1997 Results: Strong Underlying Performance Driven By Continued New Product Growth; Stock Split Proposed   Jun 26, 97 09:16 ET SmithKline Beecham's Havrix Cleared for Expanded Use   Jun 24, 97 09:04 ET IDEC Pharmaceuticals and SmithKline Beecham Place Hold on Clinical Testing of IDEC-CE9.1/SB-210396 for Treatment of Rheumatoid Arthritis   Jun 12, 97 10:01 ET SmithKline Beecham's New 5 mg Androderm(R) Testosterone Transdermal System Now Available   May 29, 97 12:04 ET Coreg (carvedilol) Cleared in the U.S. for Congestive Heart Failure; First New Approach to the Treatment of Heart Failure in 14 Years   May 16, 97 10:00 ET Famvir, from SmithKline Beecham, Approved in the UK for Suppression Of Recurrent Genital Herpes   May 13, 97 08:03 ET SmithKline Beecham and Kissei Pharmaceuticals in Agreement for New Cardiovascular Compound   May 12, 97 09:00 ET SmithKline Beecham and LG Chemical Ltd Sign Agreement For New Quinolone Antibiotic   May 06, 97 16:07 ET Denavir(TM) Clearly Demonstrates Impact on Recurrent Cold Sores, New Study Reports in JAMA   May 05, 97 09:11 ET SmithKline Beecham's Testosterone Replacement Therapy Now Available As Convenient 5 Mg Single Patch System   May 01, 97 16:45 ET Tips for Healthy Moms on Mother's Day Among Top New Features Of SmithKline Beecham Web Site   Apr 29, 97 11:05 ET Denavir (TM), Only Antiviral Cream For Treating Recurrent Cold Sores, Now Available   Apr 28, 97 09:03 ET SmithKline Beecham Dedicates $400 Million Research And Development Center   Apr 22, 97 13:12 ET SmithKline Beecham Reports First Quarter 1997 Results: Strong Underlying Performance Driven By Continued New Product Momentum   Apr 16, 97 09:16 ET SmithKline Beecham Names George Poste Chief Science and Technology Officer   Feb 27, 97 19:55 ET FDA Advisory Committee Recommends Approval of Coreg For Congestive Heart Failure   04:00 ET SmithKline Beecham Announces New Drug Discovery Collaborations   Feb 26, 97 08:44 ET Medi-Cal Cancer Patients Now Have Access To Anti-Nausea Medicine at Physicians' Offices   Feb 24, 97 10:20 ET SmithKline Beecham Settles Medicare Dispute for $325 Million   Feb 18, 97 09:06 ET Smithkline Beecham Reports Strong Growth For 1996, Fueled By Success Of New Products   08:35 ET Smithkline Beecham Reports Strong Growth For 1996, Fueled By Success Of New Products   Feb 03, 97 09:31 ET SmithKline Beecham Completes Trial of Vaccine Against Lyme Disease; License Application To Be Filed; Placebo-Treated Patients To Be Vaccinated   Jan 30, 97 09:17 ET U.S. Food And Drug Administration Licenses INFANRIX(TM) (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed)   Jan 24, 97 16:00 ET Study Shows Famvir Safe and Effective in Treating Shingles In HIV-Infected Patients   Jan 08, 97 17:07 ET Smithkline Beecham and Walter Reed Army Institute of Research Announce Promising Clinical Results Obtained With an Experimental Vaccine Against Malaria   Dec 16, 96 09:04 ET SmithKline Beecham Names Karabelas Executive Vice President of Pharmaceuticals   Oct 22, 96 07:38 ET SmithKline Beecham Announces Third-Quarter 1996 Results: Sales Grow 15 Percent; Pre-Tax Profit 20 Percent; And Earnings Per Share Increase 17 Percent   Oct 09, 96 10:00 ET SmithKline Beecham's Albenza Now Available in the U.S. For Treatment of Hydatid Cyst Disease and Neurocysticercosis   Oct 02, 96 09:35 ET Canada Clears Coreg (carvedilol) for Treatment of Heart Failure   Oct 01, 96 16:37 ET Professor Sir Colin Dollery to Join SmithKline Beecham Research and Development   Sep 25, 96 09:07 ET SmithKline Beecham's Denavir(TM), First Topical Antiviral Cream For Treatment of Cold Sores, Cleared for Marketing by FDA   Sep 23, 96 09:37 ET SB's Twinrix Vaccine Receives European Approval; First Combined Hepatitis A+B Vaccine   08:32 ET Dr. Lucy Shapiro Appointed to SmithKline Beecham Board of Directors   Sep 18, 96 15:02 ET New Studies Show Penciclovir Cream Effective Treatment For Cold Sores   15:01 ET 3-D Structure Of Cytomegalovirus Enzyme Is Published By SmithKline Beecham Scientists;   09:59 ET Study Shows Famvir(R) Effective For Suppression of Recurrent Genital Herpes   Sep 10, 96 18:37 ET Sweden Clears Carvedilol For Treatment of Heart Failure   Jul 31, 96 06:00 ET SMITHKLINE BEECHAM AND THERATECH ANNOUNCE NEW PATCH FOR TESTOSTERONE REPLACEMENT THERAPY NOW AVAILABLE IN THE UNITED KINGDOM   Jul 23, 96 07:38 ET SMITHKLINE BEECHAM ANNOUNCES SECOND-QUARTER 1996 RESULTS: SALES INCREASE 17 PERCENT; OPERATING PROFIT GROWS 14 PERCENT; EARNINGS PER SHARE RISE 12 PERCENT